Chuang Chun-Hsiang, Li Jhe-Yu, King Jung-Tai, Chen Wei-Ta, Chen Shih-Pin, Wang Yen-Feng, Liu Hung-Yu, Hsiao Fu-Jung, Pan Li-Ling Hope, Wang Shuu-Jiun, Lai Kuan-Lin
Research Center for Education and Mind Sciences, College of Education, National Tsing Hua University, Hsinchu, Taiwan.
Institute of Information Systems and Applications, College of Electrical Engineering and Computer Science, National Tsing Hua University, Hsinchu, Taiwan.
Cephalalgia. 2023 Oct;43(10):3331024231206781. doi: 10.1177/03331024231206781.
This study aimed to investigate the extent of autonomic nervous system dysfunction in patients with chronic migraine using heart rate variability analysis. In addition, we explored the potential association between heart rate variability and treatment outcomes in patients receiving preventive treatment.
In this cross-sectional and prospective study, we compared heart rate variability profiles in 81 preventive-naïve chronic migraine patients and 58 healthy controls. In addition, treatment responses of patients, who received a 12-week treatment with flunarizine, were assessed in relation to baseline heart rate variability.
We observed that chronic migraine patients had a reduced heart rate variability, signifying autonomic dysfunction in comparison to healthy controls. Furthermore, patients presenting normal heart rate variability, characterized by a standard deviation exceeding 30 milliseconds in normal-to-normal RR intervals, experienced a superior response to flunarizine treatment. This improvement was exemplified by a significantly larger reduction in monthly headache days for patients with higher heart rate variability compared to those with lower heart rate variability: -9.7 (5.9) vs. -6.2 (6.0) days ( = .026).
Autonomic dysfunction occurs in chronic migraine as evaluated by heart rate variability. A preserved function is associated with a better treatment outcome to flunarizine. Neurologic Signatures of Chronic Pain Disorders, NCT02747940. Registered 22 April 2016, https://clinicaltrials.gov/ct2/show/NCT02747940.
本研究旨在通过心率变异性分析调查慢性偏头痛患者自主神经系统功能障碍的程度。此外,我们还探讨了接受预防性治疗的患者心率变异性与治疗结果之间的潜在关联。
在这项横断面前瞻性研究中,我们比较了81例未接受过预防性治疗的慢性偏头痛患者和58例健康对照者的心率变异性特征。此外,对接受氟桂利嗪12周治疗的患者的治疗反应与基线心率变异性进行了评估。
我们观察到,与健康对照者相比,慢性偏头痛患者的心率变异性降低,这表明存在自主神经功能障碍。此外,心率变异性正常(以正常RR间期标准差超过30毫秒为特征)的患者对氟桂利嗪治疗的反应更好。心率变异性较高的患者每月头痛天数的减少幅度明显大于心率变异性较低的患者,这体现了这种改善:-9.7(5.9)天 vs. -6.2(6.0)天(P = 0.026)。
通过心率变异性评估,慢性偏头痛患者存在自主神经功能障碍。保留的功能与氟桂利嗪更好的治疗结果相关。慢性疼痛疾病的神经特征,NCT02747940。于2016年4月22日注册,https://clinicaltrials.gov/ct2/show/NCT02747940 。